BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

549 related articles for article (PubMed ID: 1567657)

  • 1. Epidermal expression of interleukin-6 and tumour necrosis factor-alpha in normal and immunoinflammatory skin states in humans.
    Oxholm A
    APMIS Suppl; 1992; 24():1-32. PubMed ID: 1567657
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Keratinocyte-expression of interleukin-6 but not of tumour necrosis factor-alpha is increased in the allergic and the irritant patch test reaction.
    Oxholm A; Oxholm P; Avnstorp C; Bendtzen K
    Acta Derm Venereol; 1991; 71(2):93-8. PubMed ID: 1675538
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of interleukin-6-like molecules and tumour necrosis factor after topical treatment of psoriasis with a new vitamin D analogue (MC 903).
    Oxholm A; Oxholm P; Staberg B; Bendtzen K
    Acta Derm Venereol; 1989; 69(5):385-90. PubMed ID: 2572101
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interleukin-6 in the epidermis of patients with psoriasis before and during PUVA treatment.
    Oxholm A; Oxholm P; Staberg B; Bendtzen K
    Acta Derm Venereol; 1989; 69(3):195-9. PubMed ID: 2566221
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interleukin-4 receptor expression in vivo on human AIDS-related Kaposi's sarcoma.
    Varricchio F; Husain SR; Leland P; Gill P; Puri RK
    Oncol Res; 1997; 9(9):495-503. PubMed ID: 9495455
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Measurement of cytokine expression and Langerhans cell migration in human skin following suction blister formation.
    Dearman RJ; Bhushan M; Cumberbatch M; Kimber I; Griffiths CE
    Exp Dermatol; 2004 Jul; 13(7):452-60. PubMed ID: 15217366
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential expression of cytokines in UV-B-exposed skin of patients with polymorphous light eruption: correlation with Langerhans cell migration and immunosuppression.
    Kölgen W; van Meurs M; Jongsma M; van Weelden H; Bruijnzeel-Koomen CA; Knol EF; van Vloten WA; Laman J; de Gruijl FR
    Arch Dermatol; 2004 Mar; 140(3):295-302. PubMed ID: 15023773
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epidermal tumour necrosis factor alpha and interleukin 6-like activities in AIDS-related Kaposi's sarcoma. An immunohistological study.
    Oxholm A; Oxholm P; Permin H; Bendtzen K
    APMIS; 1989 Jun; 97(6):533-8. PubMed ID: 2786724
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of eicosapentaenoic acid, an omega-3 fatty acid, on ultraviolet-B generation of prostaglandin-E2 and proinflammatory cytokines interleukin-1 beta, tumor necrosis factor-alpha, interleukin-6 and interleukin-8 in human skin in vivo.
    Shahbakhti H; Watson RE; Azurdia RM; Ferreira CZ; Garmyn M; Rhodes LE
    Photochem Photobiol; 2004; 80(2):231-5. PubMed ID: 15362934
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of interleukin 1beta (IL-1beta), IL-6, and tumor necrosis factor-alpha in skin of patients with fibromyalgia.
    Salemi S; Rethage J; Wollina U; Michel BA; Gay RE; Gay S; Sprott H
    J Rheumatol; 2003 Jan; 30(1):146-50. PubMed ID: 12508404
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased expression of interleukin-4 receptors on psoriatic epidermal cells.
    Prens E; Hegmans J; Lien RC; Debets R; Troost R; van Joost T; Benner R
    Am J Pathol; 1996 May; 148(5):1493-502. PubMed ID: 8623919
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ultraviolet A1-induced downregulation of human beta-defensins and interleukin-6 and interleukin-8 correlates with clinical improvement in localized scleroderma.
    Kreuter A; Hyun J; Skrygan M; Sommer A; Bastian A; Altmeyer P; Gambichler T
    Br J Dermatol; 2006 Sep; 155(3):600-7. PubMed ID: 16911288
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Intralesional and anatomopathologic features of psoriatic erythroderma].
    Samoud El Kissi S; Cherif Ben Hmida F; Ben Osman Dahri A; Boubacker MS; Hechmi-Louzir M
    Tunis Med; 2007 Jul; 85(7):573-5. PubMed ID: 18064989
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IL-1 alpha, IL-1 beta and psoriasis: conflicting results in the literature. Opposite behaviour of the two cytokines in lesional or non-lesional extracts of whole skin.
    Bonifati C; Carducci M; Mussi A; D'auria L; Ameglio F
    J Biol Regul Homeost Agents; 1997; 11(4):133-6. PubMed ID: 9582612
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Altered claudin expression is a feature of chronic plaque psoriasis.
    Watson RE; Poddar R; Walker JM; McGuill I; Hoare LM; Griffiths CE; O'neill CA
    J Pathol; 2007 Aug; 212(4):450-8. PubMed ID: 17582238
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Granulocyte colony-stimulating-factor-induced psoriasiform dermatitis resembles psoriasis with regard to abnormal cytokine expression and epidermal activation.
    Mössner R; Beckmann I; Hallermann C; Neumann C; Reich K
    Exp Dermatol; 2004 Jun; 13(6):340-6. PubMed ID: 15186319
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of contact allergens on human Langerhans cells in skin organ culture: migration, modulation of cell surface molecules, and early expression of interleukin-1 beta protein.
    Rambukkana A; Pistoor FH; Bos JD; Kapsenberg ML; Das PK
    Lab Invest; 1996 Feb; 74(2):422-36. PubMed ID: 8780161
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of cytokines and their receptors by psoriatic fibroblasts. II. decreased TNF receptor expression.
    Debets R; Hegmans JP; Buurman WA; Benner R; Prens EP
    Cytokine; 1996 Jan; 8(1):80-8. PubMed ID: 8742070
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cellular and molecular effects of pulsed dye laser and local narrow-band UVB therapy in psoriasis.
    Rácz E; de Leeuw J; Baerveldt EM; Kant M; Neumann HA; van der Fits L; Prens EP
    Lasers Surg Med; 2010 Mar; 42(3):201-10. PubMed ID: 20333742
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhanced production of biologically active interleukin-1 alpha and interleukin-1 beta by psoriatic epidermal cells ex vivo: evidence of increased cytosolic interleukin-1 beta levels and facilitated interleukin-1 release.
    Debets R; Hegmans JP; Troost RJ; Benner R; Prens EP
    Eur J Immunol; 1995 Jun; 25(6):1624-30. PubMed ID: 7614991
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.